{
  "recommendations": [
    "Administer CT Pulmonary Angiography (Chest CTA for PE) protocol.",
    "Verify patient's eGFR prior to contrast administration. If eGFR is < 30 mL/min/1.73m², consult renal safety notes and consider alternatives.",
    "Ensure adequate hydration prior to contrast administration as per ACR guidelines.",
    "Consider Low-Dose CT Chest for lung cancer screening if patient has a history of smoking, although not explicitly stated, it is a common comorbidity with the given patient profile."
  ],
  "rationale": [
    "Patient presents with shortness of breath and chest pain, which are primary indications for CT Pulmonary Angiography to rule out pulmonary embolism.",
    "eGFR is unknown and needs to be assessed before administering contrast media, as per KDIGO and ACR guidelines, especially given the patient's age and history of diabetes and hypertension which are risk factors for renal impairment.",
    "ACR guidelines emphasize hydration protocols to mitigate risks associated with contrast media administration.",
    "Low-dose CT chest is a non-contrast study, making it a safe alternative in case of compromised renal function and is a standard screening tool for lung cancer in patients with comorbidities like diabetes and hypertension, which can be associated with smoking history."
  ],
  "protocol_selection": [
    {
      "protocol_id": "CT_CHEST_ANGIO_PULMONARY_EMBOLISM",
      "name": "CT Pulmonary Angiography (Chest CTA for PE)",
      "indications": [
        "pulmonary embolism",
        "acute chest pain",
        "shortness of breath"
      ],
      "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism.",
      "contrast_timing": "Pulmonary arterial phase: 6–13 sec post-injection.",
      "contrast_dose": "Weight-based; ~100–150 mL iodinated contrast (300 mg I/mL); follow ACR Manual.",
      "renal_safety_notes": "Ensure contrast-to-eGFR ratio <1.1 g/(mL/min); if eGFR <30, consider non-contrast alternatives or weigh risks carefully.",
      "references": [
        "Contrast CT phases overview (Wikipedia):contentReference[oaicite:0]{index=0}",
        "CT pulmonary angiogram practical notes (Wikipedia):contentReference[oaicite:1]{index=1}"
      ]
    },
    {
      "protocol_id": "CT_CHEST_LOW_DOSE_SCREENING",
      "name": "Low-Dose CT Chest – Lung Cancer Screening",
      "indications": [
        "lung cancer screening",
        "high-risk cohorts"
      ],
      "description": "Low-dose CT of lungs targeting <3 mGy radiation dose while maintaining image quality.",
      "contrast_timing": "N/A – non-contrast low-dose protocol.",
      "contrast_dose": "None.",
      "renal_safety_notes": "Ideal in patients with renal dysfunction due to non-use of contrast.",
      "references": [
        "Low-dose CT screening dose benchmarks PMC:contentReference[oaicite:6]{index=6}"
      ]
    }
  ]
}